NCT04174963|Terminated
Study Stopped
Based on Initial findings and input from other researchers in the field, the investigators and sponsor decided to end this study and begin work on an updated version of this research.
Loading search results
Based on Initial findings and input from other researchers in the field, the investigators and sponsor decided to end this study and begin work on an updated version of this research.
Sponsor study identifier
interventional
12
1 country
1
Study Start
November 1, 2019
Actual (reported)Primary Completion
May 24, 2022
Actual (reported)Study Completion
May 24, 2022
Actual (reported)Cannabis use disorders are common among young adults in psychiatric treatment. Unfortunately, cannabis use can result in deleterious consequences for those in treatment, including developing more severe psychopathology and poorer treatment outcomes. Brief, electronic interventions for cannabis use have been developed for young adults. An example of a frequently used brief electronic intervention for cannabis users is e-Toke. e-Toke can be completed on a computer, tablet or phone, and has been shown to improve motivation to engage in substance use treatment among college students. However, e-Toke is less useful in decreasing the actual frequency of cannabis use. Additionally, e-toke is not tailored to young adults in psychiatric treatment. In this study, the investigators will develop and test a text messaging intervention that can be easily added to the popular computerized intervention e-Toke. The research staff hope the intervention will improve motivation to decrease cannabis use, and decrease the frequency of cannabis use, among young adults in psychiatric outpatient treatment. The text messages will be developed by, and tailored to, young adults in psychiatric treatment and texts will address motivations and barriers to reducing cannabis use in the context of psychiatric disorders. If the text message intervention is found to be an effective addition to e-Toke, this approach can be tested in a larger study, and then disseminated to other young adults in psychiatric treatment.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
May 24, 2022
Actual (reported)Click on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
November 1, 2019
Actual (reported)November 4, 2019
Actual (reported)November 22, 2019
Actual (reported)May 24, 2022
Actual (reported)May 24, 2022
Actual (reported)Change in Self-reported Frequency of Cannabis Use
This self-report will be obtained using an abbreviated version of the Alcohol, Smoking, and Substance Involvement Screening Test (ASSIST) nine times throughout the duration of the study. The abbreviated ASSIST will be administered at weeks 2, 4, 5, 6, 7, 8, 9, 10, and 11 of the study.
Assessed at weeks 2, 4, 5, 6, 7, 8, 9, 10, and 11
Change in Self-reported Motivation to Reduce Cannabis Use (SOCRATES)
Motivation to change substance use will be assessed using the Stages of Change Readiness and Treatment Eagerness Scale (SOCRATES) adapted for cannabis use (19-item questionnaires that assess recognition, ambivalence, and taking steps). Change will be assessed from baseline to 12-weeks follow-up.
Assessed at baseline and 12 weeks
Change in Self-reported Motivation to Reduce Cannabis Use (Readiness Ruler)
Motivation to change substance use will be assessed using the Readiness Ruler (rates degree of readiness to cut down ranging from 1 to 10 for twelve different substance categories). Change will be assessed from baseline to 12-weeks follow-up.
Assessed at baseline and 12 weeks
Change in Self-reported Motivation to Reduce Cannabis Use (DBI)
Motivation to change substance use will be assessed using the Decisional Balance Inventory (16-item measure of the pros and cons of substance use). Change will be assessed from baseline to 12-weeks follow-up.
Assessed at baseline and 12 weeks
Change in Self-reported Psychiatric Symptoms
Assessed at baseline and 12 weeks
Change in Self-reported Self-efficacy to Reduce Cannabis Use (SCQ-8)
Assessed at baseline and 12 weeks
All participants will receive the intervention (eToke+TPsy). The intervention consists of eToke (a brief computerized intervention that uses motivational enhancement therapy to improve readiness to decrease cannabis use and increase motivation to engage in substance use treatment) AND 6-8 interactive text messages regarding cannabis use reduction over 4 weeks . Text messages will contain written content, and queries, as well as links to publicly available websites and YouTube videos.
Combination of brief computerized intervention (eToke) with Information-Motivation-Behavior based text messages tailored to young adults in psychiatric treatment
Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
Rhode Island Hospital
Providence, Rhode Island, 02903, United States
Elliott JC, Carey KB. Correcting exaggerated marijuana use norms among college abstainers: a preliminary test of a preventive intervention. J Stud Alcohol Drugs. 2012 Nov;73(6):976-80. doi: 10.15288/jsad.2012.73.976.
Miller WR, Tonigan JS. Assessing drinkers' motivation for change: The Stages of Change Readiness and Treatment Eagerness Scale (SOCRATES). Psychology of Addictive Behaviors 10(20): 81-89, 1996.
Migneault JP, Pallonen UE, Velicer WF. Decisional balance and stage of change for adolescent drinking. Addict Behav. 1997 May-Jun;22(3):339-51. doi: 10.1016/s0306-4603(96)00252-3.
Laura Whiteley, MD
Rhode Island Hospital
Larry Brown, MD
Rhode Island Hospital
12 participants (actual enrollment reported by the registry).
First Submitted
November 4, 2019
First Posted
November 22, 2019
Study Start
November 1, 2019
Actual (reported)Reducing Cannabis Use for Sleep Among Adults Using Medical Cannabis
Contact the study team to confirm eligibility.
Derogatis LR, Melisaratos N. The Brief Symptom Inventory: an introductory report. Psychol Med. 1983 Aug;13(3):595-605.
Kirisci L, Moss HB, Tarter RE. Psychometric evaluation of the Situational Confidence Questionnaire in adolescents: fitting a graded item response model. Addict Behav. 1996 May-Jun;21(3):303-17. doi: 10.1016/0306-4603(95)00060-7.
WHO ASSIST Working Group. The Alcohol, Smoking and Substance Involvement Screening Test (ASSIST): development, reliability and feasibility. Addiction. 2002 Sep;97(9):1183-94. doi: 10.1046/j.1360-0443.2002.00185.x.
Primary Completion
May 24, 2022
Actual (reported)Study Completion
May 24, 2022
Actual (reported)Last Updated
November 18, 2023
Record last verified: 2023-11
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: